Targeted Next-Generation Sequencing for Congenital Hypothyroidism With Positive Neonatal TSH Screening
- 27 May 2020
- journal article
- research article
- Published by The Endocrine Society in Journal of Clinical Endocrinology & Metabolism
- Vol. 105 (8), e2825-e2833
- https://doi.org/10.1210/clinem/dgaa308
Abstract
Purpose Congenital hypothyroidism (CH) is the most common neonatal endocrine disorder, however, its molecular etiology remains poorly understood. Methods We performed genetic analysis of 24 causative genes using next-generation sequencing in 167 CH cases (57 dyshormonogenesis (DH), 32 dysgenesis (TD) and 78 undiagnosed). The pathogenicity of variants was assessed by the American College of Medical Genetics guidelines, inheritance pattern and published evidence. Further, we compared the oligogenic groups and monogenic groups to examine the correlation between variant dosage and severity. Results We identified variants in 66.5% cases (111/167) and fifteen genes, DUOX2, TSHR, PAX8, TG, TPO, DUOXA2, JAG1, GLIS3, DUOX1, IYD, SLC26A4, SLC5A5, SECISBP2, DIO1, and DIO3. Biallelic variants were identified in 12.6% (21/167), oligogenic in 18.0% (30/167), and monogenic in 35.9% (60/167), however, 68.5% of variants were classified as variant of unknown significance (VUS). Further examinations showed that three out of 32 cases with TD (9.4%) had pathogenic variants (two of TSHR and one of TPO), eight out of 57 cases with DH (14.0%) (seven of DUOX2, one of TG) had pathogenic variants. In addition, TSH levels at the first visit were significantly higher in the oligogenic group than in the monogenic group. Conclusions The detection rate of pathogenic variants in Japanese CH was similar to that previously reported. Moreover, oligogenic cases were likely to be more severe than monogenic cases, suggesting that CH may exhibit a gene dosage effect. Further analysis of VUS pathogenicity is required to clarify the molecular basis of CH.Keywords
This publication has 33 references indexed in Scilit:
- Congenital hypothyroidism caused by a novel mutation of the dual oxidase 2 (DUOX2) geneJournal of Pediatric Endocrinology and Metabolism, 2013
- Molecular Basis of Thyroid Dyshormonogenesis: Genetic Screening in Population-Based Japanese PatientsJournal of Clinical Endocrinology & Metabolism, 2011
- TSHRMutations as a Cause of Congenital Hypothyroidism in Japan: A Population-Based Genetic Epidemiology StudyJournal of Clinical Endocrinology & Metabolism, 2009
- Screening for mutations in transcription factors in a Czech cohort of 170 patients with congenital and early-onset hypothyroidism: identification of a novel PAX8 mutation in dominantly inherited early-onset non-autoimmune hypothyroidismActa Endocrinologica, 2007
- Haplotype Analysis Reveals Founder Effects of Thyroglobulin Gene Mutations C1058R and C1977S in JapanJournal of Clinical Endocrinology & Metabolism, 2006
- Identification and Functional Analysis of Novel Inactivating Thyrotropin Receptor Mutations in Patients with Thyrotropin ResistanceThyroid®, 2006
- Inactivating Mutations in the Gene for Thyroid Oxidase 2 (THOX2) and Congenital HypothyroidismThe New England Journal of Medicine, 2002
- Two Decades of Screening for Congenital Hypothyroidism in the Netherlands: TPO Gene Mutations in Total Iodide Organification Defects (an Update)Journal of Clinical Endocrinology & Metabolism, 2000
- Identification of five novel inactivating mutations in the human thyroid peroxidase gene by denaturing gradient gel electrophoresisHuman Mutation, 1995